Total Payments
$16,413
2024 Payments
$2,422
Companies
36
Transactions
1,061
Medicare Patients
297
Medicare Billing
$120,144
Payment Breakdown by Category
Food & Beverage$16,117 (98.2%)
Education$296.34 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,117 | 1,034 | 98.2% |
| Education | $296.34 | 27 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,781 | 105 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,688 | 85 | $0 (2024) |
| ITI, Inc. | $1,281 | 58 | $0 (2023) |
| Lundbeck LLC | $1,151 | 131 | $0 (2024) |
| Allergan, Inc. | $1,088 | 84 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $1,088 | 84 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,076 | 67 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $977.07 | 68 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $931.98 | 75 | $0 (2024) |
| ABBVIE INC. | $630.04 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,422 | 129 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($547.72) |
| 2023 | $2,448 | 118 | ITI, Inc. ($548.66) |
| 2022 | $2,412 | 143 | ITI, Inc. ($498.14) |
| 2021 | $1,673 | 99 | Neurocrine Biosciences, Inc. ($293.25) |
| 2020 | $1,759 | 112 | Vanda Pharmaceuticals Inc. ($342.18) |
| 2019 | $1,958 | 159 | Neurocrine Biosciences, Inc. ($380.26) |
| 2018 | $1,983 | 160 | Lundbeck LLC ($350.55) |
| 2017 | $1,759 | 141 | Lundbeck LLC ($399.69) |
All Payment Transactions
1,061 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Neuroscience | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: CNS | ||||||
| 12/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Neurology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.69 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Neurology | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: Neurology | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: CNS | ||||||
| 11/07/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $34.48 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: ADHD | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.15 | General |
| 10/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 72 | 508 | $62,550 | $41,943 |
| 2022 | 2 | 73 | 389 | $46,825 | $26,551 |
| 2021 | 2 | 73 | 303 | $35,175 | $20,274 |
| 2020 | 2 | 79 | 472 | $54,450 | $31,376 |
Total Patients
297
Total Services
1,672
Medicare Billing
$120,144
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 44 | 470 | $58,750 | $39,697 | 67.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 28 | 38 | $3,800 | $2,246 | 59.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 49 | 319 | $39,825 | $22,805 | 57.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 24 | 70 | $7,000 | $3,746 | 53.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 41 | 195 | $24,375 | $14,299 | 58.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 32 | 108 | $10,800 | $5,975 | 55.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 42 | 290 | $36,250 | $21,229 | 58.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 37 | 182 | $18,200 | $10,147 | 55.8% |
About Dr. Michael Lardon, M.D
Dr. Michael Lardon, M.D is a Psychiatry healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174630305.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Lardon, M.D has received a total of $16,413 in payments from pharmaceutical and medical device companies, with $2,422 received in 2024. These payments were reported across 1,061 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($16,117).
As a Medicare-enrolled provider, Lardon has provided services to 297 Medicare beneficiaries, totaling 1,672 services with total Medicare billing of $120,144. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location San Diego, CA
- Active Since 08/24/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174630305
Products in Payments
- CAPLYTA (Drug) $1,828
- INGREZZA (Drug) $1,688
- VRAYLAR (Drug) $1,579
- REXULTI (Drug) $1,357
- ARISTADA (Drug) $1,217
- LATUDA (Drug) $1,076
- TRINTELLIX (Drug) $966.32
- ABILIFY MAINTENA (Drug) $456.34
- INVEGA SUSTENNA (Drug) $416.99
- Auvelity (Drug) $394.82
- HETLIOZ (Drug) $349.59
- Dyanavel XR (Drug) $334.38
- FANAPT (Drug) $303.41
- LYBALVI (Drug) $299.51
- APLENZIN (Drug) $276.52
- Trintellix (Drug) $272.22
- Aristada 441 mg (Drug) $249.70
- BELSOMRA (Drug) $243.37
- AUSTEDO (Drug) $207.70
- UZEDY (Drug) $206.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Diego
Dr. Jonathan Meyer, M.d, M.D
Psychiatry — Payments: $2.0M
Psychiatry $2.0M
Dr. Sanjai Rao, M.d, M.D
Psychiatry — Payments: $633,149
Psychiatry $633,149
Dr. Murray Stein, M.d., M.p.h, M.D., M.P.H
Psychiatry — Payments: $115,110
Psychiatry $115,110
Dr. Mukesh Sanghadia, M.d., Mrcpsych(Uk), M.D., MRCPSYCH(UK)
Psychiatry — Payments: $82,626
Psychiatry $82,626
Dr. Neil Richtand, M.d, M.D
Psychiatry — Payments: $76,458
Psychiatry $76,458
Clark Smith, Md, MD
Psychiatry — Payments: $72,261
Psychiatry $72,261